Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin plus first-line chemotherapy for metastatic colorectal cancer with systemic inflammation
ACTRN12614000133639Phase 2Not yet recruiting
- Sponsor
- University of Sydney
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of simvastatin in colorectal cancer (CRC), sponsored by University of Sydney. Primary endpoint: Toxicity. Planned start Apr 2014; status: not yet recruiting.
02
Drugs
simvastatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ACTRN12614000133639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000133639.